Literature DB >> 33782903

Beyond Bone: Infectious Diseases and Immunity in Parathyroid Disorders.

Valeria Hasenmajer1, Giulia Puliani2,3, Marianna Minnetti2, Emilia Sbardella2, Claudio M Mastroianni4, Gabriella D'Ettorre4, Andrea M Isidori2, Daniele Gianfrilli2.   

Abstract

Parathyroid disorders are characterized by alterations in calcium and phosphate homeostasis due to inappropriately high or low levels of parathyroid hormone (PTH). Despite PTH receptor type 1 has been described in almost all immune lineages and calcium signalling has been confirmed as a crucial mediator for immune response, in vitro studies on the physiological interactions between PTH and immunity are conflicting and not representative of the clinical scenarios seen in patients with parathyroid disorders. Infectious diseases are among the main causes of increased morbidity and mortality in patients with secondary hyperparathyroidism and chronic kidney disease. More, immune alterations have been described in primary hyperparathyroidism. Recent studies have unveiled an increased risk of infections also in hypoparathyroidism, suggesting that not only calcium, but also physiological levels of PTH may be necessary for a proper immune response. Finally, calcium/phosphate imbalance could affect negatively the prognosis of infectious diseases. Our review aimed to collect available data on infectious disease prevalence in patients with parathyroid disorders and new evidence on the role of PTH and calcium in determining the increased risk of infections observed in these patients.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Hyperparathyroidism; Hypoparathyroidism; Immune function; Infectious disease; PTH

Mesh:

Substances:

Year:  2022        PMID: 33782903     DOI: 10.1007/5584_2021_629

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  87 in total

1.  Evidence of impaired T cell function in hemodialysis patients: potential role for secondary hyperparathyroidism.

Authors:  J M Alexiewicz; Z Gaciong; M Klinger; M Linker-Israeli; T O Pitts; S G Massry
Journal:  Am J Nephrol       Date:  1990       Impact factor: 3.754

2.  A longitudinal study on the effect of nifedipine therapy and its discontinuation on [Ca2+]i and proliferation of B lymphocytes of dialysis patients.

Authors:  J M Alexiewicz; M Smogorzewski; M Akmal; S G Massry
Journal:  Am J Kidney Dis       Date:  1997-02       Impact factor: 8.860

3.  Is primary hyperparathyroidism a pathogenic factor in some conditions mediated by B lymphocytes hyperactivity?

Authors:  C A Cañas; F Bonilla-Abadía; J M Anaya; G J Tobón
Journal:  Med Hypotheses       Date:  2013-05-03       Impact factor: 1.538

4.  Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss.

Authors:  Brahmchetna Bedi; Jau-Yi Li; Francesco Grassi; Hesham Tawfeek; M Neale Weitzmann; Roberto Pacifici
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

5.  Impaired humoral and cell-mediated immune responses in dialyzed patients after influenza vaccination.

Authors:  R Cappel; D Van Beers; C Liesnard; M Dratwa
Journal:  Nephron       Date:  1983       Impact factor: 2.847

Review 6.  AIRE expands: new roles in immune tolerance and beyond.

Authors:  Mark S Anderson; Maureen A Su
Journal:  Nat Rev Immunol       Date:  2016-03-14       Impact factor: 53.106

7.  Impaired phagocytosis in dialysis patients: studies on mechanisms.

Authors:  J M Alexiewicz; M Smogorzewski; G Z Fadda; S G Massry
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754

8.  Parathyroid hormone and T-cellular immunity in uremic patients in replacement dialytic therapy.

Authors:  D Angelini; A Carlini; R Giusti; R Grassi; E Mei; I Fiorini; L Mazzotta; A Antonelli
Journal:  Artif Organs       Date:  1993-02       Impact factor: 3.094

9.  SANRA-a scale for the quality assessment of narrative review articles.

Authors:  Christopher Baethge; Sandra Goldbeck-Wood; Stephan Mertens
Journal:  Res Integr Peer Rev       Date:  2019-03-26

10.  Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality.

Authors:  Irina Bancos; Jon Hazeldine; Vasileios Chortis; Peter Hampson; Angela E Taylor; Janet M Lord; Wiebke Arlt
Journal:  Eur J Endocrinol       Date:  2017-04       Impact factor: 6.664

View more
  1 in total

1.  Safety and Efficacy of PTH 1-34 and 1-84 Therapy in Chronic Hypoparathyroidism: A Meta-Analysis of Prospective Trials.

Authors:  Giulia Puliani; Valeria Hasenmajer; Ilaria Simonelli; Valentina Sada; Riccardo Pofi; Marianna Minnetti; Alessia Cozzolino; Nicola Napoli; Patrizio Pasqualetti; Daniele Gianfrilli; Andrea M Isidori
Journal:  J Bone Miner Res       Date:  2022-05-20       Impact factor: 6.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.